Raymond J. Tesi

M.D., former CEO, President and CMOatInmune Bio· In proxies 2022–2025

Pay in FY2025-5% from the year before · Inmune Bio stock -66.6% the same year

Raymond J. Tesi was paid $2.8M in FY2025 (Dec), down 5%. Inmune Bio stock fell 66.6% that year.

Pay$100 in the stock at the end of FY21 → $15

Pay is from the Summary Compensation Table of each Inmune Bio proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

INMB
Inmune BioPublic company · 4 yr
- M.D., former CEO, President and CMO2022 – Present · 4 yrStock in role -85%

Roles come from the proxy statements of each company.

Activity

Pay
Inmune Bio President pay rose 77% to $3.0M. The stock fell 59% in FY2024 (Dec).
DEF 14AApr 23, 2026
Pay
Inmune Bio President pay rose 17% to $1.7M. The stock rose 78% in FY2023 (Dec).
DEF 14AMay 29, 2024

For the press:Download CSV Download PNG How to use our data

Two people shown as one, or a wrong number?